Ayala Pharmaceuticals Inc (ADXS)

[cab033]

And that is exactly when they will get funding in my opinion.

Historically what happens when ADXS releases something good? It goes up a couple days, then goes back down, or it goes down the day they release a good PR. So why release good data now if they cant capitalize on it. Outside of the withholding data by federal law, would it not be prudent to structure everything around the same time if possible, in a good overal market/enviorment and release everything back to back, and then get funding in that 8-10 range? Items like (new partnership, good data, royalty income, sell of a franchise, ect) right around ASCO when all eyes are on Bio's. I certainly think that soulds reasonable. Why release anything now unless you have to?